Parkinson's Disease with Sleep Disorders

£680 plus travel expenses are reimbursed, or travel in a taxi is provided.

About This clinical research study

We are currently conducting a study to test a medication for people with Parkinson’s disease who experience sleep problems such as lucid/vivid dreams or re-enact dreams in their sleep. This is sometimes diagnosed as Rapid eye movement (REM) Sleep behaviour disorder (RBD).

Parkinson’s disease is defined as a condition in which the brain cells that produce Dopamine; a chemical responsible for movement, stop working properly and are lost over time.  Parkinson’s symptoms start to appear when the brain can’t make enough dopamine to control movement properly.

Sleep disorders are commonly found to occur in people living with Parkinson’s. People can physically act out vivid, often unpleasant dreams with vocal sounds and sudden, sometimes violent arm and leg movements during sleep. This is sometimes called dream-enacting behaviour.

The purpose of the trial is to test a medication that is already on the market for another condition, in the hope that it may be repurposed as a potential new treatment for Parkinson’s.

Developing a brand-new medication takes an enormous amount of time, money and effort. Getting a promising new medication into an approved drug can take around 14 years. It is crucial to advance strategies to reduce this time frame, decrease costs and improve success rates and drug repurposing is one such strategy.

Medication approved for other conditions have already been tested in people, so detailed information is available on their safety. Because repurposing builds upon previous research and development efforts, new therapies could be ready for large clinical trials quickly, speeding up their integration into health care.

£680 plus travel expenses are reimbursed, or travel in a taxi is provided.

Clinics

Greater Manchester, Lancashire and South Yorkshire

Therapy Area

Parkinson's Disease

Gender and Age

Males and Females aged 40 - 80

A full description of the study would be given to you before you decide to take part, both over the phone and during an appointment at the MAC clinic. This will include you receiving the full patient information sheet (PIS). Your GP will also be notified of your participation.

If you contact us, it does not mean you have to decide at that point whether to participate.
If you do decide to participate you are free to withdraw at any time.

All eligible participants will receive the study medication at some point during the trial.

Reimbursement: £680 plus travel expenses are reimbursed, or travel in a taxi is provided.

Key Inclusion Criteria

Key Exclusion Criteria

Other eligibility criteria will apply. Please contact MAC for more information.

Eligible patients will receive a comprehensive health screen and study participation will be in collaboration with the patient’s treating physician.

ABOUT CLINICAL RESEARCH STUDIES

Clinical research studies are performed as a way of bringing about progress in medicine and research. Clinical research studies make it possible to scientifically assess the properties of a drug, to demonstrate the effectiveness and safety of a treatment or a medical device, or to learn more about a disease and methods to diagnose and monitor it.

If the study is successful, it may be an important step towards developing a promising new treatment.

If you would like more information, please fill in the form below and we will be in touch…

Alternatively, please call our recruitment team on freephone 0800 633 5507.

  • Hidden
  • Hidden
  • (You can enter any supporting information here)
  • Hidden
  • Hidden
  • Hidden
  • Hidden
  • Hidden
Data Privacy Statement

Know someone who may be interested in taking part? Share this page here:

Share on facebook
Facebook
Share on twitter
Twitter
Share on whatsapp
WhatsApp
Share on email
Email